Afelimomab

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51202300
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51202301

This classification denotes an immunosuppressant, a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6SC756X51V. As of Q4 2014, AFELIMOMAB remains US FDA's Preferred Term for this commodity. Most nations, for tariff and trade purposes, schedule afelimomab under HS 30021000 and SITC 54163 (For the most current information on WCO designations on afelimomab and salts thereof, please see Committee proceedings HSC/18, 40.600 Ann. D, par. 6, 1996).

Same parent

Under 51202300 · 6

51202301 Afelimomab You are here 51202302 Briakinumab Commodity 51202303 Penicillamine Commodity 51202304 Penicillamine disulfide Commodity 51202305 Penicillamine hydrochloride Commodity 51202306 Etanercept Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51200000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.